U.S., Nov. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07244003) titled 'Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control' on Nov. 16.
Brief Summary: The main objective of this study is to compare the efficacy and safety of the triple combination therapy of Met/SGLT-2i/GLP-1RA or other oral antidiabetic drugs in patients with type 2 diabetes exhibiting poor glycemic control.
Study Start Date: March 29
Study Type: INTERVENTIONAL
Condition:
T2DM (Type 2 Diabetes Mellitus)
Intervention:
DRUG: Metformin
The dosage of metformin hydrochloride was consistent with baseline.
DRUG: Triple Therapy of Other Oral Antidiabetic Drugs
The dosage of metfo...